What's breaking now, across thousands of outlets.
The drugmaker's full-year revenue outlook is now $62 billion to $64 billion, up from $60.5 billion to $62.5 billion
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
The healthcare stock may finally have the catalyst that it needs to take off before the end of the year.
HAUZ offers lower costs and higher yield, but ICF's concentrated U.S. portfolio delivered 8.4% returns versus a 6.9% loss over the past year.
Markus Thielen sees Bitcoin reaching $90,000 by year-end, questions institutional ETF demand and says Ethereum must do more for holders.
Ferrari lifted its 2026 revenue forecast to near 7.65 billion euros and its industrial free cash flow forecast to up to 1.65 billion
The company's updated 2026 outlook excludes Global Print; adjusted earnings rose to 81 cents a share from 71 cents
Sam Darnold and DeMario Douglas are among the best options to consider on the fantasy football waiver wire for Week 9.
